Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, will visit the Nasdaq MarketSite in Times Square. In …
A year ago, they were trading at $3.12. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMRN at https://www.zacks.com/ap/AMRN
DUBLIN (AP) _ Amarin Corp. PLC (AMRN) on Tuesday reported a loss of $27.5 million in its fourth quarter. On a per-share basis, the Dublin-based company said it had a loss of 10 cents. Losses, adjusted for pretax expenses and stock option …
Amarin Corporation plc (AMRN) was a big mover last session, as the company saw its shares rise by over 23% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues …
Five Star Equities examines the outlook for companies in the Biotech Industry and provides equity research on Amarin …
Based on fundamentals, market trends, company events and news, and other factors, equity analysts assign price targets and recommendations to buy or sell a stock. The following graph shows how a survey of multiple analysts recommend …
Long bias on AMRN; using options to hedge can help offset the binary risk in the stock.Expect AMRN to end the day …